Anna Di Matteo

566 total citations
13 papers, 256 citations indexed

About

Anna Di Matteo is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Anna Di Matteo has authored 13 papers receiving a total of 256 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 2 papers in Cellular and Molecular Neuroscience and 2 papers in Physiology. Recurrent topics in Anna Di Matteo's work include RNA Research and Splicing (6 papers), RNA modifications and cancer (5 papers) and Neuroscience and Neuropharmacology Research (2 papers). Anna Di Matteo is often cited by papers focused on RNA Research and Splicing (6 papers), RNA modifications and cancer (5 papers) and Neuroscience and Neuropharmacology Research (2 papers). Anna Di Matteo collaborates with scholars based in Italy, United States and United Kingdom. Anna Di Matteo's co-authors include Claudia Ghigna, Elisa Belloni, Davide Pradella, Paola Frisone, Maria Paola Paronetto, Giuseppe Biamonti, Angela Amato, Fulvio Florenzano, Cinzia Severini and Serena Zacchigna and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and BioMed Research International.

In The Last Decade

Anna Di Matteo

13 papers receiving 253 citations

Peers

Anna Di Matteo
Kim D. Falkenberg Netherlands
Matthew R. Rowe New Zealand
Huiqin Dong United States
Hongbo Ling United States
Michael Martinez United States
Steven Rodriguez United States
Kim D. Falkenberg Netherlands
Anna Di Matteo
Citations per year, relative to Anna Di Matteo Anna Di Matteo (= 1×) peers Kim D. Falkenberg

Countries citing papers authored by Anna Di Matteo

Since Specialization
Citations

This map shows the geographic impact of Anna Di Matteo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Di Matteo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Di Matteo more than expected).

Fields of papers citing papers by Anna Di Matteo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Di Matteo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Di Matteo. The network helps show where Anna Di Matteo may publish in the future.

Co-authorship network of co-authors of Anna Di Matteo

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Di Matteo. A scholar is included among the top collaborators of Anna Di Matteo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Di Matteo. Anna Di Matteo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Matteo, Anna Di, Elisa Belloni, Davide Pradella, et al.. (2023). Alternative Splicing Changes Promoted by NOVA2 Upregulation in Endothelial Cells and Relevance for Gastric Cancer. International Journal of Molecular Sciences. 24(9). 8102–8102. 8 indexed citations
2.
Monti, Matilde, Jacopo Celli, Francesco Missale, et al.. (2022). Clinical Significance and Regulation of ERK5 Expression and Function in Cancer. Cancers. 14(2). 348–348. 20 indexed citations
3.
Pradella, Davide, Yoonseong Kim, Changwei Shao, et al.. (2021). Global Alternative Splicing Defects in Human Breast Cancer Cells. Cancers. 13(12). 3071–3071. 6 indexed citations
4.
Garrone, Beatrice, Anna Di Matteo, Alessandro Amato, et al.. (2021). Synergistic interaction between trazodone and gabapentin in rodent models of neuropathic pain. PLoS ONE. 16(1). e0244649–e0244649. 7 indexed citations
5.
Matteo, Anna Di, et al.. (2020). Alternative splicing in endothelial cells: novel therapeutic opportunities in cancer angiogenesis. Journal of Experimental & Clinical Cancer Research. 39(1). 275–275. 19 indexed citations
6.
Prati, Federica, Rosa Buonfiglio, Giorgina Mangano, et al.. (2020). Optimization of Indazole-Based GSK-3 Inhibitors with Mitigated hERG Issue and In Vivo Activity in a Mood Disorder Model. ACS Medicinal Chemistry Letters. 11(5). 825–831. 17 indexed citations
7.
Belloni, Elisa, Anna Di Matteo, Davide Pradella, et al.. (2019). Gene Expression Profiles Controlled by the Alternative Splicing Factor Nova2 in Endothelial Cells. Cells. 8(12). 1498–1498. 8 indexed citations
8.
Biamonti, Giuseppe, Angela Amato, Elisa Belloni, et al.. (2019). Alternative splicing in Alzheimer’s disease. Aging Clinical and Experimental Research. 33(4). 747–758. 51 indexed citations
9.
Frisone, Paola, Davide Pradella, Anna Di Matteo, et al.. (2015). SAM68: Signal Transduction and RNA Metabolism in Human Cancer. BioMed Research International. 2015. 1–14. 73 indexed citations
10.
Garrone, Beatrice, et al.. (2015). P.1.h.025 Potential involvement of metabotropic glutamate 2/3 receptors on trazodone effect on hyperalgesia in the chronic constriction injury rat model. European Neuropsychopharmacology. 25. S295–S295. 1 indexed citations
11.
Severini, Cinzia, M. T. Ciotti, Fulvio Florenzano, et al.. (2013). Bindarit, Inhibitor of CCL2 Synthesis, Protects Neurons Against Amyloid-β-Induced Toxicity. Journal of Alzheimer s Disease. 38(2). 281–293. 30 indexed citations
12.
Conforti, Erika, E. Arrigoni, Marco Piccoli, et al.. (2011). Reversine increases multipotent human mesenchymal cells differentiation potential.. PubMed. 25(2 Suppl). S25–33. 10 indexed citations
13.
Ledda, Mario, Claudio De Lazzari, Antonella Lisi, et al.. (2011). The role of extracellular conditions during CaCo-2 cells growth: a preliminary study for numerical model validation.. PubMed. 15(1). 61–70. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026